- About Us
- Research & Pipeline
- Investor Centre
- Media Centre
Our CEO, Dr James Garner recently conducted a video interview with Share Café following Kazia’s announcement of a collaboration with Dana-Farber Cancer Institute to investigate the use of paxalisib in primary central nervous system (CNS) lymphoma, a potential new indication for the drug.
In the interview, Dr Garner discusses:
Watch the video interview here.